10 years' neuroblastoma screening in Europe: preliminary results of a clinical and biological review from the study group for evaluation of neuroblastoma screening in Europe (SENSE)

By Erttmann R.   Tafese T.   Berthold F.   Kerbl R.   Mann J.   Parker L.   Schilling F.   Ambros P.   Christiansen H.   Favrot M.   Kabisch H.   Hero B.   Philip T.   on behalf of the SENSE group  

European Journal of Cancer, Vol. 34, Iss. 9, 1998-08 ,pp. : 1391-1397

Elsevier

Access to resources Recommend Favorite

Telomerase activity in neuroblastoma: is it a prognostic indicator of clinical behaviour?

By Hiyama E.   Hiyama K.   Ohtsu K.   Yamaoka H.   Ichikawa T.   Shay J.W.   Yokoyama T.  

European Journal of Cancer, Vol. 33, Iss. 12, 1997-10 ,pp. : 1932-1936

Elsevier

Access to resources Recommend Favorite

Loss of chromosome 1p may have a prognostic value in localised Neuroblastoma: results of the French NBL 90 study

By Rubie H.   Delattre O.   Hartmann O.   Combaret V.   Michon J.   Benard J.   Peyroulet M.C.   Plantaz D.   Coze C.   Chastagner P.   Baranzelli M.C.   Frappaz D.   Lemerle J.   Sommelet D.  

European Journal of Cancer, Vol. 33, Iss. 12, 1997-10 ,pp. : 1917-1922

Elsevier

Access to resources Recommend Favorite

Neuroblastoma

By Castleberry R.P.  

European Journal of Cancer, Vol. 33, Iss. 9, 1997-08 ,pp. : 1430-1437

Elsevier

Access to resources Recommend Favorite

The current contribution of molecular factors to risk estimation in neuroblastoma patients

By Berthold F.   S   ahin K.   Hero B.   Christiansen H.   Gehring M.   Harms D.   Horz S.   Lampert F.   Schwab M.   Terpe J.  

European Journal of Cancer, Vol. 33, Iss. 12, 1997-10 ,pp. : 2092-2097

Elsevier

Access to resources Recommend Favorite